FDA Approves Lupkynis 2021-01-25 mediabest Health News FDA Approves Lupkynis (voclosporin) for Adult Patients with Active Lupus Nephritis VICTORIA, British Columbia & ROCKVILLE, Md.– January 22, 2021 — Aurinia Pharmaceuticals Inc. today Read more